antioxidant · for afternoon energy crash
CoQ10
Your cells use CoQ10 to make energy, so the theory is it steadies output through the day.
Say that in clinical terms
CoQ10 supports sustained mitochondrial ATP production throughout the day. It acts as an electron carrier in the mitochondrial respiratory chain, and afternoon energy dips may partly reflect suboptimal mitochondrial bioenergetics.
How strong is the research?
2 papers read, 1 supporting.
Who was studied: 100 elite cyclists averaging 20 years old, preparing for the Olympics.
The specific symptom is the afternoon circadian energy dip — a time-of-day phenomenon tied to post-prandial and circadian rhythm biology. Searches across PubMed and general web returned no trial that recruited participants on the basis of an afternoon energy crash or that measured time-specific energy patterns through the day. What exists is: (a) trials measuring general fatigue in athletes after exercise, (b) trials measuring mild fatigue in healthy adults using subjective fatigue questionnaires (not time-anchored), and (c) trials in CFS/ME populations. None of these are equivalent endpoints. No RCT or systematic review was found that specifically tests ubiquinol for the post-lunch/afternoo
How much to take
daily with lunch
100–200 mg
Take with lunch meal to support afternoon energy. Ubiquinol form preferred for bioavailability.
Before you take it
- No established NIH ODS Tolerable Upper Intake Level (UL) for CoQ10; clinical studies have administered doses up to 1,200 mg/day without serious adverse events.
- Warfarin interaction: CoQ10 shares structural similarity with vitamin K2 and may reduce warfarin anticoagulant efficacy; INR should be monitored when initiating or stopping CoQ10 in patients on warfarin.
- Antihypertensive drugs: additive blood-pressure-lowering effect is possible; blood pressure should be monitored when CoQ10 is used concurrently with antihypertensive medication.
- Statins inhibit the mevalonate pathway and deplete endogenous CoQ10 synthesis; supplementation is commonly considered in statin-treated patients, but CoQ10 does not alter statin pharmacokinetics.
- GI effects (nausea, loose stools, epigastric discomfort) reported in some patients at doses above 200 mg/day; dividing the total daily dose reduces incidence.
- Asymptomatic LDH and hepatic transaminase elevations have been reported in some studies at doses above 300 mg/day; clinical significance is unclear.
- Pregnancy and lactation: safety not established; avoid without medical supervision.
When to take it
Best taken: with food
What we make of it
A real trial in 100 elite cyclists, which is not the question being asked.
The detail
The study is genuine and correctly cited, with 100 participants. But they were elite cyclists preparing for the Olympics, and an afternoon energy crash was not what it measured.